Severely depressed or schizophrenic patients could benefit enormously from tests that
reveal which
drug and dose will help them the most, but unlike
asthma,
drug response can be difficult to quantify biologically, making gene -
drug relations tougher to pin down.
From their success in
revealing the basic mechanisms of
asthma, six new
drugs have entered clinical testing for
asthma, many others are in pre-clinical testing, and scores of new molecular pathways underlying
asthma have been
revealed.